NCT04385199View on ClinicalTrials.gov

Convalescent Plasma for Patients With COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

August 1, 2020

Study Completion Date

August 1, 2020

Conditions
Coronavirus InfectionCoronavirusCOVID
Interventions
BIOLOGICAL

Convalescent plasma

One 200mL transfusion of ABO compatible convalescent plasma over 3 hours

Trial Locations (1)

48202

Henry Ford Hospital, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT04385199 - Convalescent Plasma for Patients With COVID-19 | Biotech Hunter | Biotech Hunter